Literature DB >> 15971356

Mitochondrial myopathy, sideroblastic anemia, and lactic acidosis: an autosomal recessive syndrome in Persian Jews caused by a mutation in the PUS1 gene.

Avraham Zeharia1, Nathan Fischel-Ghodsian, Kari Casas, Yelena Bykhocskaya, Hana Tamari, Dorit Lev, Marc Mimouni, Tally Lerman-Sagie.   

Abstract

We report the seventh case of autosomal recessive inherited mitochondrial myopathy, lactic acidosis, and sideroblastic anemia The patient, a product of consanguineous Persian Jews, had the association of mental retardation, dysmorphic features, lactic acidosis, myopathy, and sideroblastic anemia. Muscle biopsy demonstrated low activity of complexes 1 and 4 of the respiratory chain. Electron microscopy revealed paracrystalline inclusions in most mitochondria. Southern blot of the mitochondrial DNA did not show any large-scale rearrangements. The patient was found to be homozygous for the 656C-->T mutation in the pseudouridine synthase 1 gene (PUS1). Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia is an oxidative phosphorylation disorder causing sideroblastic anemia, myopathy, and, in some cases, mental retardation that is due to mutations in the nuclear-encoded PUS1 gene. This finding provides additional evidence that mitochondrial ribonucleic acid modification impacts the phenotypic expression of oxidative phosphorylation disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15971356     DOI: 10.1177/08830738050200051301

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  29 in total

1.  Sideroblastic anaemia and primary adrenal insufficiency due to a mitochondrial respiratory chain disorder in the absence of mtDNA deletion.

Authors:  Michael J O'Grady; Ahmad A Monavari; Melanie Cotter; Nuala P Murphy
Journal:  BMJ Case Rep       Date:  2015-02-26

2.  Recurrent heteroplasmy for the MT-ATP6 p.Ser148Asn (m.8969G>A) mutation in patients with syndromic congenital sideroblastic anemia of variable clinical severity.

Authors:  Simon Berhe; Matthew M Heeney; Dean R Campagna; John F Thompson; Eric J White; Tristen Ross; Roy W A Peake; Jeffery D Hanrahan; Vilmarie Rodriguez; Deborah L Renaud; Mrinal S Patnaik; Eugenia Chang; Sylvia S Bottomley; Mark D Fleming
Journal:  Haematologica       Date:  2018-07-13       Impact factor: 9.941

3.  A previously unidentified activity of yeast and mouse RNA:pseudouridine synthases 1 (Pus1p) on tRNAs.

Authors:  Isabelle Behm-Ansmant; Séverine Massenet; Françoise Immel; Jeffrey R Patton; Yuri Motorin; Christiane Branlant
Journal:  RNA       Date:  2006-06-27       Impact factor: 4.942

4.  Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome.

Authors:  Lisa G Riley; Sandra Cooper; Peter Hickey; Joëlle Rudinger-Thirion; Matthew McKenzie; Alison Compton; Sze Chern Lim; David Thorburn; Michael T Ryan; Richard Giegé; Melanie Bahlo; John Christodoulou
Journal:  Am J Hum Genet       Date:  2010-07-09       Impact factor: 11.025

5.  Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA).

Authors:  Erika Fernandez-Vizarra; Angela Berardinelli; Lucia Valente; Valeria Tiranti; Massimo Zeviani
Journal:  BMJ Case Rep       Date:  2009-06-09

6.  Variants in PUS7 Cause Intellectual Disability with Speech Delay, Microcephaly, Short Stature, and Aggressive Behavior.

Authors:  Arjan P M de Brouwer; Rami Abou Jamra; Nadine Körtel; Clara Soyris; Daniel L Polla; Modi Safra; Avia Zisso; Christopher A Powell; Pedro Rebelo-Guiomar; Nadja Dinges; Violeta Morin; Michael Stock; Mureed Hussain; Mohsin Shahzad; Saima Riazuddin; Zubair M Ahmed; Rolph Pfundt; Franziska Schwarz; Lonneke de Boer; André Reis; Detilina Grozeva; F Lucy Raymond; Sheikh Riazuddin; David A Koolen; Michal Minczuk; Jean-Yves Roignant; Hans van Bokhoven; Schraga Schwartz
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

Review 7.  Mass spectrometry of the fifth nucleoside: a review of the identification of pseudouridine in nucleic acids.

Authors:  Anita Durairaj; Patrick A Limbach
Journal:  Anal Chim Acta       Date:  2008-06-26       Impact factor: 6.558

8.  Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G>A) in the mitochondrial encoded ATP6 gene.

Authors:  Lindsay C Burrage; Sha Tang; Jing Wang; Taraka R Donti; Magdalena Walkiewicz; J Michael Luchak; Li-Chieh Chen; Eric S Schmitt; Zhiyv Niu; Rodrigo Erana; Jill V Hunter; Brett H Graham; Lee-Jun Wong; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2014-06-30       Impact factor: 4.797

9.  Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations.

Authors:  Anke K Bergmann; Dean R Campagna; Erin M McLoughlin; Suneet Agarwal; Mark D Fleming; Sylvia S Bottomley; Ellis J Neufeld
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

10.  Matrix-assisted laser desorption/ionization mass spectrometry screening for pseudouridine in mixtures of small RNAs by chemical derivatization, RNase digestion and signature products.

Authors:  Anita Durairaj; Patrick A Limbach
Journal:  Rapid Commun Mass Spectrom       Date:  2008-12       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.